Traditional immunoassay methods, such as IHC, ELISA, and IF, are still widely used for PD-L1 detection, but novel immunoassays with higher sensitivity, real-time monitoring, and less tumor heterogeneity, such as electrochemical immunoassay, photochemical immunoassay, and nuclear medicine imaging, are emerging trends in this field. Here, CD274 is linked to neoplasm.